118 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
marked.
Forward-looking statements are based on certain assumptions regarding the Company and anticipated benefits from the new director's experience … the benefits, expected; risks that the Company's products may not be accepted and adopted by the public; the risk that the Company will not obtain CE mark
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
cell identity markers of significant interest for use in isolating specific cell populations from the tissue biopsy. Potential benefits include … that the Company’s products may not perform as, or have the benefits, expected; risks that the Company’s products may not be accepted and adopted
6-K
07mxvi jr
24 Nov 10
Current report (foreign)
12:00am
6-K
xeh5v34udiz4sf2j9yu
26 Oct 11
Current report (foreign)
12:00am
6-K
bvyfye30rkjkea
17 May 12
Current report (foreign)
12:00am
6-K
EX-99.1
whrra k4dk4r17pwlonw
18 Oct 18
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
9:06am
6-K
m4lmy099u8g
23 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
d233v6p
7 Jul 22
Statement of Executive Compensation
1:43pm
6-K
EX-99.1
yxxlqbz1zabv
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
9aj9nrsyv0
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
4fp6zdow2i6 ngr2
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
snxga3sr57el42iwb
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.1
zlf0bs9dq6 9aebv2w
11 Oct 18
RepliCel Life Sciences Completes Financing with YOFOTO (China) Health
11:45am
6-K
7jejxux3 13x75oo
15 Oct 09
Current report (foreign)
12:00am
CORRESP
7q5jv
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
q50 ch8at
25 Oct 17
Current report (foreign)
12:00am